๐ต๏ธ Lisata Therapeutics, Inc. ($LSTA)
SEC insider & ownership activity, last 12 months ยท CIK 320017 ยท every row links its SEC filing
Insiders were quiet over the last 12 months โ no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Jul 24, 2026 | filing โ |
| Other events (8.01) | Jul 24, 2026 | filing โ |
| Material agreement (1.01) | Jul 16, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing โ |
| Material agreement (1.01) | Jun 8, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing โ |
| Other events (8.01) | Jun 1, 2026 | filing โ |
| Material agreement (1.01) | May 29, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing โ |
| Material agreement (1.01) | May 3, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 3, 2026 | filing โ |
| Other events (8.01) | Apr 15, 2026 | filing โ |
| Other events (8.01) | Apr 2, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Apr 2, 2026 | filing โ |
| Material agreement (1.01) | Mar 6, 2026 | filing โ |
| Reg FD disclosure (7.01) | Mar 6, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing โ |
| Material agreement (1.01) | Feb 27, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing โ |
| Other events (8.01) | Jan 27, 2026 | filing โ |
| Material agreement (1.01) | Jan 20, 2026 | filing โ |
| Other events (8.01) | Jan 20, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing โ |
| Earnings (2.02) | Nov 6, 2025 | filing โ |
| Reg FD disclosure (7.01) | Nov 6, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing โ |
| Reg FD disclosure (7.01) | Oct 14, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 14, 2025 | filing โ |
| Material agreement (1.01) | Oct 8, 2025 | filing โ |
| Earnings (2.02) | Aug 7, 2025 | filing โ |